Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dayer

Showing results (131-140 of 283) with videos related to

Pageof 29
Sort By:
The New England Journal of Medicine|August 21, 1980
Inhibition by retinoic acid of collagenase production in rheumatoid synovial cellsC E Brinckerhoff, R M McMillan, J M Dayer, et al.
The Journal of Allergy and Clinical Immunology|August 1, 1991
Anti-interleukin-1 alpha autoantibodies in humans: characterization, isotype distribution, and receptor-binding inhibition--higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia)J H Saurat, J Schifferli, G Steiger, et al.
Collagen and Related Research|March 1, 1985
Mononuclear cell-conditioned medium containing mononuclear cell factor (MCF), homologous with interleukin 1, stimulates collagen and fibronectin synthesis by adherent rheumatoid synovial cells: effects of prostaglandin E2 and indomethacinS M Krane, J M Dayer, L S Simon, et al.
Biochemical and Biophysical Research Communications|July 28, 1978
A cell strain cultured from porcine kidney increases cyclic AMP content upon exposure to calcitonin or vasopressinS R Goldring, J M Dayer, D A Ausiello, et al.
Arthritis and Rheumatism|May 1, 1995
Dysregulation of the in vivo production of interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Pathogenetic implicationsI C Chikanza, P Roux-Lombard, J M Dayer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1981
Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1)S B Mizel, J M Dayer, S M Krane, et al.
Calcified Tissue International|January 1, 1981
Factors modulating the response of a porcine renal tubular cell line to calcitonin and antidiuretic hormoneJ F Héron, J M Dayer, S R Goldring, et al.
The Journal of Rheumatology|April 1, 1992
Inhibitors of interleukin 1 activity in synovial fluids and in cultured synovial fluid mononuclear cellsP Roux-Lombard, C Modoux, T Vischer, et al.
The Journal of Biological Chemistry|September 2, 1994
Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expressionS Lacraz, P Isler, E Vey, et al.
Infection and Immunity|October 1, 1991
Tumor necrosis factor and interleukin-1 activities in free lung cells after single and repeated inhalation of bacterial endotoxinB de Rochemonteix-Galve, B Marchat-Amoruso, J M Dayer, et al.
Pageof 29

Showing results (131-140 of 283) with videos related to

Sort By:
Pageof 29
The New England Journal of Medicine|August 21, 1980
Inhibition by retinoic acid of collagenase production in rheumatoid synovial cellsC E Brinckerhoff, R M McMillan, J M Dayer, et al.
The Journal of Allergy and Clinical Immunology|August 1, 1991
Anti-interleukin-1 alpha autoantibodies in humans: characterization, isotype distribution, and receptor-binding inhibition--higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia)J H Saurat, J Schifferli, G Steiger, et al.
Collagen and Related Research|March 1, 1985
Mononuclear cell-conditioned medium containing mononuclear cell factor (MCF), homologous with interleukin 1, stimulates collagen and fibronectin synthesis by adherent rheumatoid synovial cells: effects of prostaglandin E2 and indomethacinS M Krane, J M Dayer, L S Simon, et al.
Biochemical and Biophysical Research Communications|July 28, 1978
A cell strain cultured from porcine kidney increases cyclic AMP content upon exposure to calcitonin or vasopressinS R Goldring, J M Dayer, D A Ausiello, et al.
Arthritis and Rheumatism|May 1, 1995
Dysregulation of the in vivo production of interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Pathogenetic implicationsI C Chikanza, P Roux-Lombard, J M Dayer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1981
Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1)S B Mizel, J M Dayer, S M Krane, et al.
Calcified Tissue International|January 1, 1981
Factors modulating the response of a porcine renal tubular cell line to calcitonin and antidiuretic hormoneJ F Héron, J M Dayer, S R Goldring, et al.
The Journal of Rheumatology|April 1, 1992
Inhibitors of interleukin 1 activity in synovial fluids and in cultured synovial fluid mononuclear cellsP Roux-Lombard, C Modoux, T Vischer, et al.
The Journal of Biological Chemistry|September 2, 1994
Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expressionS Lacraz, P Isler, E Vey, et al.
Infection and Immunity|October 1, 1991
Tumor necrosis factor and interleukin-1 activities in free lung cells after single and repeated inhalation of bacterial endotoxinB de Rochemonteix-Galve, B Marchat-Amoruso, J M Dayer, et al.
Pageof 29